Clinical trials: Irisin Gene Polymorphism in Type II Diabetic Patients
Irisin Gene Polymorphism in Type II Diabetic Patients
Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD
This is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism and the presence and severity of coronary artery…
- Trial name
- CAD (NCT04957823)
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Sohag University